Development of an Effective Polyvalent Vaccine against both Marek's and Newcastle Diseases Based on Recombinant Marek's Disease Virus Type 1 in Commercial Chickens with Maternal Antibodies

An earlier report (M. Sakaguchi et al., Vaccine 16:472–479, 1998) showed that recombinant Marek's disease virus type 1 (rMDV1) expressing the fusion (F) protein of Newcastle disease virus (NDV-F) under the control of the simian virus 40 late promoter [rMDV1-US10L(F)] protected specific pathogen-free...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	J Virol
المؤلفون الرئيسيون:	Sonoda, Kengo, Sakaguchi, Masashi, Okamura, Hiroshi, Yokogawa, Kenji, Tokunaga, Eiji, Tokiyoshi, Sachio, Kawaguchi, Yasushi, Hirai, Kanji
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	American Society for Microbiology (ASM) 2000
الموضوعات:	Vaccines and Antiviral Agents
الوصول للمادة أونلاين:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC111822/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10708438/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.74.7.3217-3226.2000
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!